Interview- Meet Our New FAS, Lisa Creary

We are happy to announce that Lisa Creary joined Omixon as a Field Application Scientist effective October, 2020.  In the following mini-interview Lisa talks about her passion, experiences and thoughts on HLA activities. Welcome Lisa! How did you become a scientist? My first experience of science dates back many moons...

 

Read more

Omixon Launches OmniType, Multiplex For NGS-based HLA Genotyping

Omixon proudly announces the launch of OmniType, a 11-locus multiplex human leukocyte antigen (HLA) genotyping assay and software product for use on the Illumina® sequencing platforms (such as MiSeq, MiniSeq and iSeq). OmniType offers a revolutionary single working-day workflow that allows processing of samples from gDNA to a ready-to-sequence...

 

Read more

Webinar em Português – Atualizações do HLA Twin v4.2 e Análise de Dados de Amostras Difíceis

  Junte-se a nós para um webinar com Gustavo Milson (Technical Sales Specialist) e Renata Santos (Senior Field Application Scientist). Neste webinar, queremos proporcionar informações das atualizações da nova versão do HLA Twin v4.2, e uma introdução de como revisar amostras no software. Vamos revisar a análise de amostra...

 

Read more

Interview with Prof. Milena Ivanova MD, Molecular Biologist from the University Hospital Aleksandrovska

The following interview is part of our interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. In this interview, Prof. Milena Ivanova MD, Molecular Biologist from the University Hospital Aleksandrovska talks about their experiences and thoughts on HLA laboratory activities....

 

Read more

HLA EXPLORE™ can help you in your COVID research and Omixon offers 50% off the annual licence fee for Research Institutions until the end of 2020

HLA Explore NGS software can analyze any experiment type – targeted exons, targeted whole genes, whole MHC, whole transcriptome, whole exome or whole genome – of your patient’s NGS samples.   While recovering from the COVID crises Omixon offers 50% off the annual licence fee for Research Institutions until the...

 

Read more